ArticleJournal of molecular neuroscience : MN2025
Can Oxidative Stress Biomarkers Differentiate Trichotillomania from Obsessive-Compulsive Disorder and Healthy Controls?
Article in Journal of molecular neuroscience : MN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated oxidative stress biomarkers in differentiating trichotillomania (TTM), obsessive-compulsive disorder (OCD), and healthy controls (HC), focusing on thiol-disulfide homeostasis, total oxidant status (TOS), total antioxidant status (TAS), and ischemia-modified albumin (IMA). A total of 68 adolescent females aged 10-18 were recruited and divided into three groups: TTM (n = 24), OCD (n = 21), and HC (n = 23). Oxidative stress biomarkers were assessed through blood analyses, including measurements of thiol-disulfide homeostasis, TOS, TAS, and IMA. Blood analyses revealed that TTM patients had significantly lower native and total thiol levels, a reduced native/total thiol ratio, and elevated disulfide levels compared to OCD and HC (p < 0.01). ROC analysis indicated that the native thiol/total thiol ratio effectively distinguished TTM from both HC and OCD with high accuracy. These findings reveal distinct oxidative stress patterns in TTM and OCD, with disrupted thiol-disulfide homeostasis in TTM and elevated oxidative burden in OCD. The discriminative power of the native thiol/total thiol ratio suggests molecular-level differences, which may inform the etiopathogenesis of TTM and support the development of targeted treatment strategies.
Indexed as
Identifiers
41037227What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.